TY - JOUR
T1 - A synonymous variant in scavenger receptor, class B, type I gene is associated with lower SR-BI protein expression and function
AU - Constantineau, Jason
AU - Greason, Erin
AU - West, Michael
AU - Filbin, Megan
AU - Kieft, Jeffrey S.
AU - Carletti, Martha Z.
AU - Christenson, Lane K.
AU - Rodriguez, Annabelle
N1 - Funding Information:
This work was supported by a NIH NHLBI grant ( HL075646 ) to Dr. Annabelle Rodriguez.
PY - 2010/5
Y1 - 2010/5
N2 - Objective: A synonymous variant within scavenger receptor class B type I gene (SCARB1), exon 8 rs5888, has been associated with altered lipid levels and cardiovascular risk in humans. The objective was to determine if rs5888 decreased SR-BI protein expression and function in vitro. Methods: SR-BI RNA secondary structure, turnover, polysomal distribution and protein expression were examined in COS cells transfected with wild-type or rs5888-SR-BI plasmids by selective 2′-hydroxyl acylation and primer extension assays, actinomycin D inhibition, polysomal profiling, and western blotting. SR-BI function in murine macrophages stably expressing wild-type or rs5888-SR-BI was assessed by measuring the specific cell association of 125I,3H-cholesteryl ester (CE) radiolabeled HDL. Results: Rs5888 changed RNA secondary structure and led to marked differences in the polysomal profiles compared with wild-type transcript (p<0.02). As compared to wild-type cells, COS cells expressing rs5888 had significantly lower SR-BI protein expression (p<0.04), but no difference in total RNA transcript levels. There were no differences in SR-BI RNA turnover in murine macrophages, whereas specific cell association of 125I (p<0.0001) or 3H-CE (p<0.00001) was significantly lower in rs5888 cells. Conclusions: The rs5888 variant affected SR-BI RNA secondary structure, protein translation, and was significantly associated with reduced SR-BI protein expression and function in vitro.
AB - Objective: A synonymous variant within scavenger receptor class B type I gene (SCARB1), exon 8 rs5888, has been associated with altered lipid levels and cardiovascular risk in humans. The objective was to determine if rs5888 decreased SR-BI protein expression and function in vitro. Methods: SR-BI RNA secondary structure, turnover, polysomal distribution and protein expression were examined in COS cells transfected with wild-type or rs5888-SR-BI plasmids by selective 2′-hydroxyl acylation and primer extension assays, actinomycin D inhibition, polysomal profiling, and western blotting. SR-BI function in murine macrophages stably expressing wild-type or rs5888-SR-BI was assessed by measuring the specific cell association of 125I,3H-cholesteryl ester (CE) radiolabeled HDL. Results: Rs5888 changed RNA secondary structure and led to marked differences in the polysomal profiles compared with wild-type transcript (p<0.02). As compared to wild-type cells, COS cells expressing rs5888 had significantly lower SR-BI protein expression (p<0.04), but no difference in total RNA transcript levels. There were no differences in SR-BI RNA turnover in murine macrophages, whereas specific cell association of 125I (p<0.0001) or 3H-CE (p<0.00001) was significantly lower in rs5888 cells. Conclusions: The rs5888 variant affected SR-BI RNA secondary structure, protein translation, and was significantly associated with reduced SR-BI protein expression and function in vitro.
KW - Atherosclerosis
KW - HDL
KW - SCARB1
KW - SNPs
KW - SR-BI
KW - Synonymous
UR - http://www.scopus.com/inward/record.url?scp=77952546323&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952546323&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2009.11.029
DO - 10.1016/j.atherosclerosis.2009.11.029
M3 - Article
C2 - 20060115
AN - SCOPUS:77952546323
SN - 0021-9150
VL - 210
SP - 177
EP - 182
JO - Atherosclerosis
JF - Atherosclerosis
IS - 1
ER -